HCG703.50

Healthcare Global Enterprises Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹10,123 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,912.12,222.92,545.42,627.4
Other Income16.934.825.030.3
Total Income1,929.12,257.72,570.42,657.6
Expenses
+ Purchases of Stock-in-Trade479.4590.2701.7722.2
+ Changes in Inventories-4.0-9.6-9.4-13.0
+ Employee Benefit Expense308.2353.5378.6385.4
+ Finance Costs108.7154.6176.6171.0
+ Depreciation & Amortisation174.4211.3244.2256.7
+ Other Expenses798.9901.51,008.71,052.5
Total Expenses1,865.62,201.52,500.42,574.7
EBITDA329.6387.3465.8480.3
EBIT155.2175.9221.6223.6
Profit
PBT before Exceptional Items63.456.270.082.9
+ Exceptional Items3.90.0-44.6-44.6
Pretax Income67.356.225.538.3
+ Current Tax34.328.719.819.6
+ Deferred Tax-7.9-20.5-15.6-12.8
Tax Expense26.48.14.16.8
+ Share of Associates & JVs0.40.81.51.7
Net Income41.348.822.833.3
+ Net Income — Continuing Ops40.948.121.331.6
+ Other Comprehensive Income-0.51.84.64.8
Total Comprehensive Income40.950.627.338.1
Net Income to Common48.144.413.822.8
Minority Interest-6.84.49.010.5
Per Share
Basic EPS3.463.190.971.55
Diluted EPS3.433.140.961.55
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs0.40.81.5
Other Comprehensive Income — detail
+ Other Comprehensive Income1.84.64.8
+ Items NOT to be Reclassified to P&L-0.70.10.70.8
+ Tax on Items NOT to be Reclassified0.00.00.1
+ Items to be Reclassified to P&L0.21.73.84.1
Comprehensive Income — Owners of Parent47.746.04.64.9
Comprehensive Income — Non-controlling Interests-6.94.60.0-0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations3.463.190.971.55
Diluted EPS — Continuing Operations3.433.140.961.55
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,436.71,642.31,853.11,918.1
Gross Margin %75.1473.8872.8073.01
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)63.456.270.082.9
− Exceptional Items (reconciliation)3.90.0-44.6-44.6
Net Income Adj (tax-effected)38.948.860.170.0
EPS Adj3.263.192.563.26
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital139.3139.4143.9149.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.